T. Slabiak

Oncogenic potential of bcl-2 demonstrated by gene transfer

P. Nowell, C. Croce, John Calvin Reed, 1988, Nature.

Regulation of bcl-2 gene expression in lymphoid cell lines containing normal #18 or t(14;18) chromosomes.

P. Nowell, C. Croce, John Calvin Reed, 1989, Oncogene research.

Selective glycogen synthase kinase 3 inhibitors potentiate insulin activation of glucose transport and utilization in vitro and in vivo.

Kirk W. Johnson, Sylvia Ma, J. Nuss, 2003, Diabetes.

Development of a Screening Assay for Surrogate Markers of Chk1 Inhibitor-Induced Cell Cycle Release

E. Moler, C. Fanton, M. L. Mackichan, 2006, Journal of biomolecular screening.